Experimental studies of Elaphostrongylus rangiferi in reindeer (Rangifer tarandus tarandus): life cycle, pathogenesis, and pathology.

A total of 12 reindeer calves (Rangifer tarandus tarandus) were given 200-1,000 infective larvae of Elaphostrongylus rangiferi and autopsied 2 1/2-196 days post inoculation (p.i.).

Xylazine-induced sedation in axis deer (Axis axis) and its reversal by atipamezole.

Eight free-ranging axis deer (Axis axis) were captured in drive nets and injected with xylazine (3.4 +/- 0.1 mg/kg; mean +/- SEM) intramuscularly using a hand-held syringe.

Chemical capture of free-ranging cattle: immobilization with xylazine or medetomidine, and reversal with atipamezole.

Twenty-nine free-ranging Norwegian cattle were captured with xylazine (n = 20) or medetomidine (n = 9) using a tranquilizing gun, and the time from darting to recumbency (induction time) was recorded. Twenty-eight animals were given atipamezole IV 15-100 min after darting, and the effects of the antagonist were evaluated. Blood samples (n = 19) for haematology and serum chemistry were collected within 10 min after immobilization was induced.

Reversal of xylazine-induced sedation in dairy calves with atipamezole: a field trial.

Dairy calves immobilized with xylazine (XYL) were given atipamezole-HCl (ATI) at different XYL:ATI dose ratios (w/w) for reversal and the antagonistic effect of xylazine was evaluated. Control animals received saline for comparison. Intramuscular administration of xylazine (0.

Lethal cerebrospinal elaphostrongylosis in a reindeer calf.

Lethal elaphostrongylosis in a reindeer calf is described. The calf showed signs of abnormal behaviour, mental confusion and reduced vision due to lesions in the brain parenchyma caused by migrating mature Elaphostrongylus rangiferi. Traumatically caused malacia and secondary axon degeneration were observed in all brain areas.

Immobilization of mink (Mustela vison) with medetomidine-ketamine and remobilization with atipamezole.

Four groups of mink were immobilized with medetomidine-HCl (MED) 0.1 mg/kg + ketamine (KET) 5 or 7.5 mg/kg at different ambient temperatures.